Management of polycystic ovary syndrome in adolescence

Reviews in Gynaecological Practice

Volumn 4, Issue 3, 2004, Pages 148-155

  Homburg, Roy ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Acne; Adolescence; Anti androgens; Hirsutism; Metformin; Polycystic ovary syndrome

Indexed keywords

ANDROGEN; ANTIANDROGEN; BENZOYL PEROXIDE; CYPROTERONE ACETATE; DIANE; ERYTHROMYCIN; FINASTERIDE; FLUTAMIDE; KETOCONAZOLE; METFORMIN; MINOCYCLINE; SPIRONOLACTONE; TETRACYCLINE;

ACNE; ADOLESCENCE; ADOLESCENT; ANDROGEN RELEASE; APPETITE DISORDER; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; DRUG MECHANISM; EARLY DIAGNOSIS; ECHOGRAPHY; FEMALE; GASTROINTESTINAL SYMPTOM; GLUCOSE TOLERANCE; HEADACHE; HIRSUTISM; HUMAN; INSULIN SENSITIVITY; LIBIDO DISORDER; MASTALGIA; MENSTRUAL IRREGULARITY; OBESITY; OLIGOMENORRHEA; OVARY POLYCYSTIC DISEASE; PRECOCIOUS PUBERTY; REVIEW; SEBACEOUS GLAND; SOCIAL PSYCHOLOGY; SYMPTOMATOLOGY; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; WEIGHT REDUCTION;

EID: 4444285462     PISSN: 14717697     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rigp.2004.02.001     Document Type: Review

References (46)

1. Van Hooff M.H.A. Voorhoorst F.J. Kaptein M.B.H. Hirasing R.A. Koppenaal C.Schoemaker J.Endocrine features of polycystic ovary syndrome in a random population sample 14-16 year-old adolescents Hum Reprod 14 1999 2223-2229
2. Siegberg R. Nilsson C.G. Stenman U.H. Widhold O. Endocrinologic features of oligomenorrheic adolescent girls Fertil Steril 46 1986 852-857
3. Apter D. Vihko R. Endocrine determinants of fertility: serum androgen concentrations during follow-up of adolescents into the third decade of life J Clin Endocrinol Metab 71 1990 970-974
4. Silfen M.E. Denburg M.R. Manibo A.M. Lobo R.A. Jaffe R. Ferin M. et al. Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome: comparison between nonobese and obese adolescents J Clin Endocrinol Metab 88 2003 4682-4688
5. Legro R.S. Detection of insulin resistance and its treatment in adolescents with polycystic ovary syndrome J Pediatr Endocrinol Metab 15 Suppl 5 2002 1367-1378
6. Rosenfield R.L. Ghai K. Ehrmann D.A. Barnes R.B. Diagnosis of the polycystic ovary syndrome in adolescence: comparison of adolescent and adult hyperandrogenism J Pediatr Endocrinol Metab 13 Suppl 5 2000 1285-1289
7. Ibanez L. Ong K.K. Mongan N. Jaaskelainen J. Marcos M.V. Hughes I.A. et al. Androgen receptor gene CAG repeat polymorphism in the development of ovarian hyperandrogenism J Clin Endocrinol Metab 88 2003 3337-3338
8. Jonard S. Robert Y. Cortet C. Decanter C. Dewailly D. Ultrasound examination of polycystic ovaries: Is it worth counting the follicles? Hum Reprod 18 2003 598-603
9. Kent SC. Legro R.S. Polycystic ovary syndrome in adolescents Adolesc Med 13 2002 73-88
10. Erkokola R. Ruutiainen K. Hirsutism: definitions and etiology Ann Med 22 1990 99-103
11. Adams J. Polson DW. Franks S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism Br Med J 293 1986 355-359
12. Dramusic V. Rajan U. Wong Y.C. Ratnam S.S. Wong Y.C. Adolescent polycystic ovary syndrome Ann NY Acad Sci 816 1997 194-208
13. Bunker C.B. Newton J. Kilborn J. Patel A. Conway G.S.Jacobs H.S. et al. Most women with acne have polycystic ovaries Br J Dermatol 121 1989 675-680
14. Betti R. Bencini PL. Lodi A. Urbani C.E. Chiarelli G. Crosti C. Incidence of polycystic ovaries in patients with late onset or persistent acne: hormonal reports Dermatologica 181 1990 109-111
15. Jebraili R. Kaur S. Kanwar AJ. Kataria S. Dash R.J. Hormone profile and polycystic ovaries in acne vulgaris Indian J Med Res 100 1994 73-76
16. Balen A.H. Conway G.S. Kaltsas G. Techatrasak K. Manning P.J. West C. et al. Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients Hum Reprod 10 1995 2705-2712
17. Robinson S. Kiddy D. Gelding S.V. Willis D. Niththyananthan R. Bush A. et al. The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries Clin Endocrinol 39 1993 351-355
18. Paus R. Cotsarelis G. The biology of hair follicles N Engl J Med 341 1999 491-497
19. Toscano V. Balducci R. Bianchi P. Guglielmi R. Mangiantini A. Rossi F.G. et al. Two different pathogenic mechanisms may play a role in acne and in hirsutism Clin Endocrinol (Oxf) 39 1993 551-556
20. Bunker C.B. Newton J.A. Conway G.S. Jacobs H.S. Greaves M.W. Dowd P.M. The hormonal profile of women with acne and polycystic ovaries Clin Exp Dermatol 16 1991 420-423
21. Legro R.S. Bentley-Lewis R. Driscoll D. Wang S.C. Dunaif A. Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity J Clin Endocrinol Metab 87 2002 2128-2133
22. Poretsky L. Cataldo N.A. Rosenwaks Z. Giudice L.C. The insulin related ovarian regulatory system in health and disease Endoc Rev 20 1999 535-582
23. Kiddy D.S. Hamilton-Fairley D. Bush A. Short F. Anyaoku V. Reed M.J. et al. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome Clin Endocrinol 36 1992 105-111
24. Pasquali R. Antenucci D. Casmirri F. Venturoli S. Paradisi R. Fabbri R. et al. Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss J Clin Endocrinol Metab 68 1989 173-179
25. Clark A.M. Thornley B. Tomlinson L. Galletley C. Norman R.J. Weight loss results in significant improvement in reproductive outcome for all forms of fertility treatment Hum Reprod 13 1998 1502-1505
26. Pasquali R. Gambineri A. Biscotti D. Vicennati V. Gagliardi L. Colitta D. et al. Effect of long term treatment with metformin added to hypocaloric diet on body composition, fat distribution and androgen and insulin levels in abdominally obese women with and without polycystic ovary syndrome J Clin Endocrinol Metab 85 2000 2767-2774
27. Moghetti P. Castello R. Negri C. Tosi F. Perrone F. Caputo M. et al. Metformin effects on clinical features, endocrine and metabolic profiles and insulin sensitivity in polycystic ovary syndrome: a randomized, double blind, placebo-controlled 6-month trial, followed by open, long term clinical evaluation J Clin Endocrinol Metab 85 2000 139-146
28. Legro R.S. Polycystic ovary syndrome: current and future treatment paradigms Am J Obstet Gynecol 1795 1998 S101
29. Jamieson M.A. The use of metformin in adolescents with polycystic ovary syndrome J Pediatr Adolesc Gynecol 15 2002 109-114
30. Glueck C.J. Wang P. Fontaine R. Tracy T. Sieve-Smith L. Metformin to restore normal menses in oligo-amenorrheic teenage girls with polycystic ovary syndrome J Adolesc Health 29 2001 160-169
31. Ibanez L. Valls C. Ferrer A. Marcos M.V. Rodriguez-hiero F. de Zegher F. Sensitization to insulin induces ovulation in nonobese adolescents with anovulatory hyperandrogenism J Clin Endocrinol Metab 86 2001 3595-3598
32. Ibanez L. Ong K. Ferrer A. Amin R. Dunger D. de Zegher F. Low dose flutamide-metformin therapy reverses insulin resistance and reduces fat mass in nonobese adolescents with ovarian hyperandrogenism J Clin Endocrinol Metab 88 2003 2600-2606
33. Diamanti-Kandarakis E. Tolis G. Duleba A. Androgens and therapeutic aspects of anti-androgens in women. 1995 2 577-92
34. Golland I.M. Elstein M.E. Results of an open one-year study with diane-35 in women with polycystic ovarian syndrome. 1993 687 263-8
35. Sarih Y. Diber S. Kelestimur F. Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism Fertil Steril 75 2001 496-500
36. Van Waygen R.G. van den Ende A. Experience in the long term treatment of hisutism and/or acne with cyproterone acetate-containing preparations. Efficacy Exp Clin Endocrinol Diabetes 103 1995 241-251
37. Spritzer P.M. Opperman-Lisboa K. Mattiello S. Lhulier F. Spironolactone as a single agent for long term therapy of hirsute patients Clin Endocrinol 52 2000 587-594
38. Moghetti P. Tosi F. Tosti A. Negri C. Misciali C. Perrone F. et al. Comparison of spironolactone, flutamide and finasteride efficacy in the treatment of hirsutism: a randomized, double-blind, placebo controlled trial J Clin Endocrinol Metab 85 2000 89-94
39. Moghetti P. Castello R. Negri C. Tosi F. Magnani C.M. Fontanarosa M.C. et al. Flutamide in the treatment hirsutism: long term clinical effects Fertil Steril 64 1995 511-517
40. Venturoli S. Marescalchi O. Colombo F.M. Macrelli S. Ravaioli B. Bagnoli A. et al. A prospective randomized trial comparing low dose flutamide, finasteride, ketoconazole and cyproterone acetate-estrogen regimens in the treatment of hirsutism J Clin Endocrinol Metab 84 1999 1304-1310
41. Falsetti L. De Fusco D. Elefttheriou G. Rosina B. Treatment of hirsutism by finasteride and flutamide in women with polycystic ovary syndrome Gynecol Endocrinol 11 1997 251-257
42. Erenus M. Yucelten D. Gurbuz O. Durmusoglu F. Perkin S. Comparison of spironolactone-oral contraceptive versus cyproterone acetate-estrogen regimens in the treatment of hirsutism Fertil Steril 66 1996 216-219
43. Yucelten D. Erenus M. Gurbuz O. Durmusoglu F. Recurrence rate of hirsutism after 3 different anti-androgen therapies J Am Acad Dermatol 41 1999 64-68
44. Flagmini C. Venturoli S. Fabbri R. Long term management of hirsute patients with cyproterone acetate. In: Spona J, Aydinlik S, editors. Hirsutism and endocrine dermatological problems. Carnforth, Lancs: Parthenon Press; p. 29-37.
45. Kokaly W. McKenna T.J. Relapse of hirsutism following long-term successful treatment with oestrogen-progesterone combination Clin Endocrinol 2000 52 1988 379-382
46. Harborne L. Fleming R. Lyall H. Norman J. Sattar N. Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome Lancet 361 2003 1894-1900